Enzymatica AB (publ) operates within the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Enzymatica AB (publ) with three other
pharmaceutical manufacturers in Europe:
sales of 4.26 million Euro [US$4.77 million]
of which 100%
Premier Veterinary Group PLC
of the United Kingdom
(£2.99 million [US$3.88 million]
Collagen Solutions PLC
based in the United Kingdom
(£3.13 million [US$4.06 million]
During the year ended December of 2016, sales at
Enzymatica AB (publ) were SEK 36.48 million (US$4.19 million).
increase of 30.7%
versus 2015, when the company's sales were SEK 27.91 million.
This was the fifth consecutive year of sales increases at Enzymatica AB (publ)
(and since 2011, sales have increased a total of 5,325%).